PMID- 34534510
OWN - NLM
STAT- MEDLINE
DCOM- 20220422
LR  - 20221207
IS  - 1538-2990 (Electronic)
IS  - 0002-9629 (Linking)
VI  - 363
IP  - 3
DP  - 2022 Mar
TI  - Effects of Mobile Phone-Based Telemedicine Management in Patients With Type 2 
      Diabetes Mellitus: A Randomized Clinical Trial.
PG  - 224-231
LID - S0002-9629(21)00313-X [pii]
LID - 10.1016/j.amjms.2021.09.001 [doi]
AB  - BACKGROUND: This study aims to explore the effect of mobile phone-based 
      telemedicine management of glycemic control of type 2 diabetes mellitus (T2DM). 
      METHODS: Patients with T2DM were followed up in Chongqing Jiulongpo District 
      Yuzhoulu Community Health Center, and randomly divided into the telemedicine 
      group (n=47) and the control group (n=50). The control group received regularly 
      routine intervention. The telemedicine management group used the mobile phone to 
      manage their health condition remotely. RESULTS: Both groups had similar baseline 
      characteristics. After a follow-up period of 12 months intervention, the weight, 
      body mass index, waist circumference, systolic blood pressure, body fat 
      percentage, body fat mass, body water and muscle mass, fasting blood glucose, 
      glycosylated hemoglobin, total costs of diabetes treatment for 1 month and the 
      quality-of-life score were significantly improved in the telemedicine group 
      (P<0.05). And compared with the control group, body fat composition, fasting 
      blood glucose, glycosylated hemoglobin and the cost of change shows a significant 
      improvement (P<0.05). Positive correlation was detected between fasting blood 
      glucose and body composition parameters, such as body fat percentage, lean body 
      mass and body fat mass in the telemedicine group (r=0.56, P<0.05; r=0.37, P<0.05; 
      r=0.56, P<0.05). CONCLUSIONS: Compared with conventional intervention, the mobile 
      phone-based telemedicine management can help patients with T2DM to improve 
      glycemic level and quality of life.
CI  - Copyright (c) 2021 Southern Society for Clinical Investigation. Published by 
      Elsevier Inc. All rights reserved.
FAU - Yang, Li
AU  - Yang L
AD  - Departments of Nutriology of Xinqiao Hospital, Army Medical University, 
      Chongqing, P.R. China; Chongqing Jiulongpo District Health Center for Women and 
      Children, Chongqing, P.R. China.
FAU - Xu, Jing
AU  - Xu J
AD  - Department of Endocrinology of Xinqiao Hospital, Army Medical University, 
      Chongqing, P.R. China.
FAU - Kang, Chao
AU  - Kang C
AD  - Department of Nutriology of The General Hospital of Western Theater Command, 
      Chengdu, Sichuan Province, P.R. China.
FAU - Bai, Qian
AU  - Bai Q
AD  - Departments of Nutriology of Xinqiao Hospital, Army Medical University, 
      Chongqing, P.R. China.
FAU - Wang, Xiangyu
AU  - Wang X
AD  - Departments of Nutriology of Xinqiao Hospital, Army Medical University, 
      Chongqing, P.R. China.
FAU - Du, Shanshan
AU  - Du S
AD  - Departments of Nutriology of Xinqiao Hospital, Army Medical University, 
      Chongqing, P.R. China.
FAU - Zhu, Wenyi
AU  - Zhu W
AD  - Departments of Nutriology of Xinqiao Hospital, Army Medical University, 
      Chongqing, P.R. China.
FAU - Wang, Jian
AU  - Wang J
AD  - Departments of Nutriology of Xinqiao Hospital, Army Medical University, 
      Chongqing, P.R. China. Electronic address: 673375499@qq.com.
LA  - eng
PT  - Journal Article
PT  - Randomized Controlled Trial
PT  - Research Support, Non-U.S. Gov't
DEP - 20210914
PL  - United States
TA  - Am J Med Sci
JT  - The American journal of the medical sciences
JID - 0370506
RN  - 0 (Blood Glucose)
RN  - 0 (Glycated Hemoglobin A)
SB  - IM
MH  - Blood Glucose
MH  - *Cell Phone
MH  - *Diabetes Mellitus, Type 2/therapy
MH  - Glycated Hemoglobin/analysis
MH  - Humans
MH  - Quality of Life
MH  - *Telemedicine
OTO - NOTNLM
OT  - Glycemic Control
OT  - Telemedicine
OT  - Type 2 diabetes mellitus
COIS- Declaration of Competing Interest The authors have declared no conflict of 
      interest.
EDAT- 2021/09/18 06:00
MHDA- 2022/04/23 06:00
CRDT- 2021/09/17 20:10
PHST- 2020/08/03 00:00 [received]
PHST- 2021/05/19 00:00 [revised]
PHST- 2021/09/10 00:00 [accepted]
PHST- 2021/09/18 06:00 [pubmed]
PHST- 2022/04/23 06:00 [medline]
PHST- 2021/09/17 20:10 [entrez]
AID - S0002-9629(21)00313-X [pii]
AID - 10.1016/j.amjms.2021.09.001 [doi]
PST - ppublish
SO  - Am J Med Sci. 2022 Mar;363(3):224-231. doi: 10.1016/j.amjms.2021.09.001. Epub 
      2021 Sep 14.